Fellowship · Rochester, NY
Sponsored by University of Rochester Medicine
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.
Nature · 2023 · 372 citations · Darren A. Tabechian, Jennifer Anolik
IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy.
Frontiers in immunology · 2024 · 116 citations · Christopher T. Ritchlin
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.
JID innovations : skin science from molecules to population health · 2022 · 196 citations · Lisa A. Beck
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet (London, England) · 2023 · 137 citations · Christopher T. Ritchlin
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet (London, England) · 2023 · 137 citations · Christopher T. Ritchlin
Granzyme K+ CD8 T cells form a core population in inflamed human tissue.
Science translational medicine · 2022 · 251 citations · Jennifer Anolik
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis.
Arthritis care & research · 2023 · 96 citations · Allen P. Anandarajah, Anatole K. Kleiner
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.
JAMA dermatology · 2024 · 59 citations · Lisa A. Beck